EICKELMANN, PETER,MARK, MICHAEL,SEMAN, LEO JOHN,THOMAS, LEO,BROEDL, ULI,GREMPLER, ROLF
申请号：
CA2751833
公开号：
CA2751833C
申请日:
2010.02.11
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The invention relates to the treatment or prevention of one or more conditionsselected from type 1 diabetes mellitus,type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using aSGLT-2 inhibitor. In addition the presentinvention relates to methods for preventing or treating of metabolic disordersand related conditions.
